Careers Contact Locations

OPKO Health, Inc.

  • Home
  • Who We Are
    • Our Vision
    • Our History
    • Our Leadership
  • What We Do
    • Overview
    • Our Products
    • Our Solutions
    • Our Technology
    • Our Research
    • Our Diagnostics
  • News & Media
    • Press Releases
    • Announcements
    • Events
    • Presentations
    • Fact Sheets
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact
  • Locations

Press Releases

Investors

Investors

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Form 8937
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity

Jun 11, 2018

OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test

May 18, 2018

OPKO Health Reports First Quarter 2018 Financial Results

May 8, 2018

OPKO Health to Announce First Quarter 2018 Financial Results on May 8, 2018

May 2, 2018

OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories

May 1, 2018

OPKO Health to Remain on the Tel Aviv Stock Exchange

Apr 27, 2018

OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes

Mar 23, 2018

OPKO Health Announces Landmark Study Showing 4KscoreĀ® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology

Mar 16, 2018

OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results

Mar 1, 2018

OPKO Health to Announce Fourth Quarter and Year End 2017 Financial Results on March 1, 2018

Feb 26, 2018
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...37
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
    © 2019 OPKO Health, Inc. All Rights Reserved.
    Privacy Policy Governance Terms of Use Sitemap